2012 ©
             Publication
Journal Publication
Research Title Inhibition of Nrf2 signaling sensitizes cholangiocarcinoma cells to cisplatin in association with cellular oxidative stress  
Date of Distribution 29 December 2015 
Conference
     Title of the Conference Advanced Oxidative Stress Research for Health Benefits and Well beings 
     Organiser Society for Free Radical Research – Asia (SFRR-Asia 2015) 
     Conference Place The empress hotel 
     Province/State Chiang mai, Thailand 
     Conference Date 29 November 2015 
     To 2 December 2015 
Proceeding Paper
     Volume 2558 
     Issue
     Page 65 
     Editors/edition/publisher SFRR-Thai 
     Abstract Introduction: Drug resistance is the main obstacle to cancer chemotherapy. Cancer of the bile duct (cholangiocarcinoma:CCA) is the devastating malignancy, as it is poorly response to chemotherapy. The nuclear factor erythroid 2-like 2 (Nrf2) is activated by oxidative stress and contributes to cytoprotection in cancer cells. The association of oxidant stress by Nrf2 inhibition and chemosensitizing effect to cisplatin in CCA cells was investigated. Materials and methods: CCA cell lines were analyzed for the expression of Nrf2. The Nrf2 expression was suppressed by siRNA and antioxidant gene expression was analyzed by reverse-transcription PCR and Western blotting. The cytotoxicity was assayed by acridine-orange/ethidium bromide and sulforhodamine-B assays. Results and discussion: KKU-100 and M156 cells with high and low Nrf2 expression were employed to examine the effect of Nrf2 silencing. Knockdown of Nrf2 enhanced the cytotoxicity to cisplatin in both cell lines by 3-6 fold and independence of basal Nrf2 expression. Suppression of Nrf2 resulted in suppression of cisplatin-induced antioxidant gene expression, Nrf2, GCLC and HO-1. Oxidant formation in Nrf2 knockdown cells was implicated in the chemosensitizing effect, as the effect was largely abolished by treatment with superoxide scavenger, Tempol or redox modifier, N-acetylcysteine. Inhibition of Nrf2 signaling could be a novel target to enhance the sensitivity to chemotherapy in CCA.  
Author
547070027-6 Miss PAPAVEE SAMATIWAT [Main Author]
Medicine Doctoral Degree

Peer Review Status มีผู้ประเมินอิสระ 
Level of Conference นานาชาติ 
Type of Proceeding Abstract 
Type of Presentation Poster 
Part of thesis true 
Presentation awarding true 
     Award Title Young Investigator Award 
     Type of award รางวัลด้านวิชาการ วิชาชีพ 
     Organiser SFRR-Thai 
     Date of awarding 2 ธันวาคม 2558 
Attach file
Citation 0